Published in Nature on December 09, 1967
Separation of viable Rickettsia typhi from yolk sac and L cell host components by renografin density gradient centrifugation. Appl Microbiol (1975) 6.55
Growth and physiology of rickettsiae. Bacteriol Rev (1973) 4.04
Plaque assay for Rickettsia rickettsii. J Bacteriol (1969) 3.77
Plaque assay system for several species of Rickettsia. J Bacteriol (1969) 2.68
Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Rickettsia akari. Infect Immun (1971) 2.40
Some characteristics of heavy and light bands of Rickettsia prowazekii on Renografin gradients. Infect Immun (1981) 2.18
Biochemical and immunochemical analysis of Rickettsia rickettsii strains of various degrees of virulence. Infect Immun (1984) 2.12
Effects of various suspending media on plaque formation by rickettsiae in tissue culture. Infect Immun (1972) 2.10
Energy metabolism of Rickettsia typhi: pools of adenine nucleotides and energy charge in the presence and absence of glutamate. J Bacteriol (1978) 1.81
Substrate utilization by Ehrlichia sennetsu and Ehrlichia risticii separated from host constituents by renografin gradient centrifugation. J Bacteriol (1988) 1.75
Enzymatic activities of cell-free extracts of Rickettsia typhi. Infect Immun (1976) 1.50
Glutamate catabolism of Rickettsia rickettsi and factors affecting retention of metabolic activity. J Bacteriol (1968) 1.46
Reactivation of Rickettsia rickettsii in Dermacentor andersoni ticks: an ultrastructural analysis. Infect Immun (1982) 1.45
Rocky Mountain spotted fever: a disease in need of microbiological concern. Clin Microbiol Rev (1989) 1.32
Biological properties of Rickettsia prowazekii strains isolated from flying squirrels. Infect Immun (1977) 1.26
Ultrastructural studies of Rickettsia prowazeki from louse midgut cells to feces: search for "dormant" forms. Infect Immun (1974) 1.17
Adenine nucleotide degradation by the obligate intracellular bacterium Rickettsia typhi. Infect Immun (1980) 1.10
Humoral immune response to Rocky Mountain spotted fever in experimentally infected guinea pigs: immunoprecipitation of lactoperoxidase 125I-labeled proteins and detection of soluble antigens of Rickettsia rickettsii. Infect Immun (1986) 1.07
Biochemistry of Coxiella burnetii: 6-phosphogluconic acid dehydrogenase. J Bacteriol (1970) 1.06
Ornithine metabolism in the genus Rochalimaea. J Bacteriol (1982) 0.96
Use of 33P as an indicator for 32P pulse labeling of nucleic acids in bacterial cultures. J Bacteriol (1970) 0.79
Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol (1986) 9.90
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol (1985) 6.78
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet (1989) 6.58
Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol (1987) 4.70
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol (1985) 4.05
Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation. J Infect Dis (1988) 3.96
The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother (1986) 3.94
Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines. Clin Exp Immunol (1971) 3.74
Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis (1987) 3.69
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Work of a district ethical committee. Br Med J (1979) 3.64
Experimental lepromatous leprosy. Nature (1967) 3.18
Electron-transparent zone of mycobacteria may be a defence mechanism. Nature (1970) 3.18
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Agent transmissible from Crohn's disease tissue. Lancet (1970) 2.89
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature (1966) 2.63
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
Helicobacter nemestrinae sp. nov., a spiral bacterium found in the stomach of a pigtailed macaque (Macaca nemestrina) Int J Syst Bacteriol (1991) 2.37
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Comparison of technics for the isolation of T-strain mycoplasmas. Nature (1969) 2.02
A transmissible agent from sarcoid tissue. Lancet (1969) 2.02
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
Enhancing effect of antilymphocytic serum on mycobacterial infections in mice. Nature (1968) 1.97
Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. Clin Exp Immunol (1983) 1.95
Computer printing and filing of microbiology reports. 1. Description of the system. J Clin Pathol (1976) 1.92
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
Immune responses in mice with murine leprosy. Clin Exp Immunol (1970) 1.79
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Biology of the mycobacterioses. Experimental models for studying leprosy. Ann N Y Acad Sci (1968) 1.78
Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Br J Dermatol (1966) 1.77
The nasal dicharge in leprosy: clinical and bacteriological aspects. Lepr Rev (1974) 1.76
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother (1974) 1.76
Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet (1994) 1.73
Cefuroxime: pharmacokinetics after a short infusion, and in vitro activity against hospital pathogens. J Antimicrob Chemother (1977) 1.70
Intracellular vacuolization caused by the urease of Helicobacter pylori. J Infect Dis (1990) 1.70
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells. J Gen Microbiol (1973) 1.67
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Coronaviridae. Intervirology (1975) 1.55
Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54
INTRAVITREOUS STREPTOMYCIN: ITS TOXICITY AND DIFFUSION. Br J Ophthalmol (1948) 1.53
Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad. Int J Lepr (1966) 1.53
A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43
Experimental and clinical studies on rifampicin in treatment of leprosy. Br Med J (1970) 1.43
Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42
Some immunologic aspects of leprosy. Am Rev Respir Dis (1965) 1.41
Will antibacterial chemotherapy be efficacious for gastritis and peptic ulcer? J Antimicrob Chemother (1986) 1.40
The use of the voluntary muscle test in leprosy neuritis. Lepr Rev (1968) 1.40
Computer printing and filing of microbiology reports. 2. Evaluation and comparison with a manual system, and comparison of two manual systems. J Clin Pathol (1976) 1.40
Live influenza vaccines. Lancet (1983) 1.39
Urine tests to monitor the self-administration of dapsone by leprosy patients. Am J Trop Med Hyg (1974) 1.39
The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39
Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38
Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust (1985) 1.37
Picornaviridae. Intervirology (1974) 1.36
Site of multiplication of human leprosy bacilli inoculated into the foot-pads of mice. Nature (1965) 1.35
Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study. J Med Microbiol (1987) 1.35
Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
The advantages of HeLa cells for isolation of rhinoviruses. J Med Microbiol (1974) 1.32
Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet (1976) 1.30